Infinion™ Data Could Buoy Boston Scientific’s Declining SCS Share

Data presented at the International Spine Intervention Society (ISIS) 20th Annual Scientific Meeting demonstrated that Boston Scientific’s (NYSE: BSX) Infinion™ 16 Percutaneous Lead effectively relieved pain in patients suffering from chronic pain, according to a statement on Wednesday from the company. The ‘lead’ delivers electrical pulse signals from an implanted device, designed to mask ‘pain signals’ sent to the brain. Data collected from two studies designed to evaluate the 16 Percutaneous Lead system revealed a statistically significant outcome in pain intensity and pain relief  for sufferers (p<0.0001). (more…)